Detection of COVID-19 in Saliva Collection

Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample.

Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sars-CoV2 Nasopharyngeal Sample RT-PCR Saliva Collection

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Amiens

Amiens, 80480, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient hospitalized at the Amiens CHU in a COVID-19 unit
patient seen as outpatient in the area of infectious pathologies for COVID-19 infection

Exclusion criteria

Patients under 18
patients under guardianship or curators

Treatment and study plan

Primary outcomes

Detection of SARS-CoV-2 RNA in the saliva sample

Time frame: day 1

Detection of SARS-CoV-2 RNA in the saliva sample
Concordance between the Saliva sample and the nasonasopharyngeal sample SARS-CoV-2 RT-PCR results

Time frame: day 1

Concordance between the Saliva sample and the nasonasopharyngeal sample SARS-CoV-2 RT-PCR results

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Official study title

Evaluation of the Performance of a Saliva Sample Versus a Nasopharyngeal Sample in the Diagnosis of COVID-19 by RT-PCR

Acronym: SALICOV

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: May 13, 2020
Registry last updated: Dec 11, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed